From July 1st to January 1st, 2025, this study was carried out in a chicken farm in Babylon Governorate to investigate the use of nano-zinc for coccidiosis treatment. 360 laying hens were utilized, divided into four treatments of 90 laying hens each, and then further divided into replicates of 30 laying hens each. The treatments were T1 (no addition), T2 (80 ppm nano-zinc/L), T3 (100 ppm nano-zinc/L), and T4 (120 ppm nano-zinc/L). The results show: significant )P<0.05) increase for T1 treatment in cholesterol and triglyceride in 28 days, 56 days and, 28 days respectively, significant )P<0.05) increase for T1 treatment in ALT in 28 days and, 56 days respectively compared other treatments, while in AST (28 and 56 days) noted not significant deference among treatments, significant )P<0.05) increase for T2, T3, and T4 treatments in total protein at 28 and 56 days, significant )P<0.05) increase for T2 treatment in IgG at 28 days, at 56 days significant )P<0.05) increase for T3 treatment in IgM.From July 1st to January 1st, 2025, this study was carried out in a chicken farm in Babylon Governorate to investigate the use of nano-zinc for coccidiosis treatment. 360 laying hens were utilized, divided into four treatments of 90 laying hens each, and then further divided into replicates of 30 laying hens each. The treatments were T1 (no addition), T2 (80 ppm nano-zinc/L), T3 (100 ppm nano-zinc/L), and T4 (120 ppm nano-zinc/L). The results show: significant )P<0.05) increase for T1 treatment in cholesterol and triglyceride in 28 days, 56 days and, 28 days respectively, significant )P<0.05) increase for T1 treatment in ALT in 28 days and, 56 days respectively compared other treatments, while in AST (28 and 56 days) noted not significant deference among treatments, significant )P<0.05) increase for T2, T3, and T4 treatments in total protein at 28 and 56 days, significant )P<0.05) increase for T2 treatment in IgG at 28 days, at 56 days significant )P<0.05) increase for T3 treatment in IgM.
Kazem et al. (Tue,) studied this question.